Axsome Therapeutics Inc (AXSM) Insider Trading
- $1,126,079.78
- $50,482,849.05
- Feb. 2, 2026
- Mark Coleman
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 2, 2026 | CEO | 32,410 | $185.60 | Sell | $6,015,296.00 | |
| Sept. 22, 2025 | COO | 10,000 | $115.96 | Sell | $1,159,600.00 | |
| Sept. 16, 2025 | COO | 45,783 | $114.48 | Sell | $5,241,237.84 | |
| Sept. 16, 2025 | CEO | 19,719 | $114.19 | Sell | $2,251,712.61 | |
| Sept. 15, 2025 | CEO | 15,254 | $117.37 | Sell | $1,790,361.98 | |
| Sept. 12, 2025 | CEO | 27,907 | $118.96 | Sell | $3,319,816.72 | |
| Sept. 8, 2025 | Director | 1,575 | $127.28 | Buy | $200,466.00 | |
| Sept. 5, 2025 | Director | 9,127 | $125.07 | Sell | $1,141,513.89 | |
| Sept. 2, 2025 | Director | 13,464 | $123.68 | Sell | $1,665,227.52 | |
| Aug. 28, 2025 | Director | 20,000 | $121.60 | Sell | $2,432,000.00 | |
| Aug. 26, 2025 | Director | 20,000 | $120.03 | Sell | $2,400,600.00 | |
| Aug. 22, 2025 | Director | 16,694 | $120.08 | Sell | $2,004,615.52 | |
| June 23, 2025 | General Counsel | 6,014 | $100.12 | Sell | $602,121.68 | |
| June 20, 2025 | General Counsel | 7,500 | $102.47 | Sell | $768,525.00 | |
| June 17, 2025 | General Counsel | 7,500 | $100.26 | Sell | $751,950.00 | |
| June 9, 2025 | COO | 25,000 | $110.44 | Sell | $2,761,000.00 | |
| May 28, 2025 | COO | 20,000 | $103.45 | Sell | $2,069,000.00 | |
| May 27, 2025 | COO | 20,673 | $104.66 | Sell | $2,163,636.18 | |
| May 27, 2025 | Director | 3,750 | $105.47 | Sell | $395,512.50 | |
| May 20, 2025 | Director | 3,000 | $107.49 | Sell | $322,470.00 | |
| Feb. 14, 2025 | CFO | 3,000 | $131.07 | Sell | $393,210.00 | |
| Sept. 11, 2024 | Director | 11,016 | $91.31 | Sell | $1,005,870.96 | |
| Aug. 9, 2024 | COO | 47,739 | $84.26 | Sell | $4,022,488.14 | |
| May 29, 2024 | COO | 7,910 | $74.31 | Sell | $587,792.10 | |
| May 28, 2024 | Director | 5,249 | $75.21 | Sell | $394,777.29 | |
| April 1, 2024 | COO | 24,662 | $77.24 | Sell | $1,904,892.88 | |
| March 14, 2024 | Director | 29,976 | $69.70 | Sell | $2,089,327.20 | |
| Sept. 15, 2023 | Director | 11,016 | $75.19 | Sell | $828,293.04 | |
| Nov. 19, 2021 | Director | 3,950 | $37.30 | Buy | $147,335.00 | |
| Nov. 18, 2021 | CFO | 527 | $35.50 | Buy | $18,708.50 | |
| Nov. 17, 2021 | Director | 3,000 | $34.53 | Buy | $103,590.00 | |
| May 12, 2021 | Director | 500 | $58.15 | Buy | $29,075.00 | |
| June 29, 2020 | CFO | 777 | $76.64 | Buy | $59,549.28 | |
| June 29, 2020 | Director | 650 | $78.50 | Buy | $51,025.00 | |
| Sept. 26, 2019 | CFO | 2,180 | $24.80 | Buy | $54,064.00 | |
| June 25, 2019 | Director | 400 | $23.25 | Buy | $9,300.00 | |
| June 11, 2019 | CFO | 1,920 | $20.80 | Buy | $39,936.00 | |
| May 23, 2019 | Director | 3,500 | $22.33 | Buy | $78,155.00 | |
| May 13, 2019 | Director | 4,650 | $21.44 | Buy | $99,696.00 | |
| March 19, 2019 | CFO | 5,400 | $12.58 | Buy | $67,932.00 | |
| March 19, 2019 | Director | 5,100 | $12.18 | Buy | $62,118.00 | |
| June 19, 2018 | CFO | 31,000 | $3.10 | Buy | $96,100.00 | |
| Dec. 23, 2015 | Insider | 1,000 | $9.03 | Buy | $9,030.00 |
Insiders are both buying and selling Axsome Therapeutics Inc stock.
The insider traders at Axsome Therapeutics Inc are: Mark Coleman, Mark L Jacobson, Nick Pizzie, Roger Jeffs, Mark E Saad, Herriot Tabuteau, Hunter R. Murdock, Mark L. Jacobson, and Randall Kaye
The most active insider trader at Axsome Therapeutics Inc is Mark Coleman with 10 trades.
Herriot Tabuteau has sold the most Axsome Therapeutics Inc stock with a total value of $19,392,483.31.
Mark Coleman has bought the most Axsome Therapeutics Inc stock with a total value of $652,146.00.
The most recent insider trade for Axsome Therapeutics Inc was on Feb. 2, 2026.
The single biggest insider buy for Axsome Therapeutics Inc was from Mark Coleman with a total value of $200,466.00 on Sept. 8, 2025.
The single biggest insider sell for Axsome Therapeutics Inc was from Herriot Tabuteau with a total value of $6,015,296.00 on Feb. 2, 2026.
